Evidence map›Paper›PMID 39560842›Full record

ArticleMedical oncology (Northwood, London, England)2024

Red wavelength-induced photobiomodulation enhances indocyanine green-based anticancer photodynamic therapy.

Büşra Sirek, Nermin Topaloğlu

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Büşra SirekDepartment of Biomedical Sciences, Graduate School of Natural and Applied Sciences, Izmir Katip Celebi University, Izmir, Turkey.ORCID http://orcid.org/0000-0002-2788-1149
Nermin TopaloğluDepartment of Biomedical Engineering, Faculty of Engineering and Architecture, Izmir Katip Celebi University, Izmir, Turkey. nermin.topaloglu@ikcu.edu.tr.ORCID http://orcid.org/0000-0001-7001-8327

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a global concern worldwide. Prostate cancer has high prevalence and mortality rates among men. Photodynamic therapy (PDT) is an alternative treatment that is promising and effective with fewer side-effects than conventional therapies. However, some factors may limit its efficacy. For this, PDT can be combined with other modalities such as photobiomodulation (PBM) which is commonly used for increased cell proliferation/differentiation and wound healing. In this study, PBM pre-treatment at 655 nm of wavelength with 1, 3, and 5 J/cm

Indexed as

Indocyanine GreenLow-Level Light TherapyPhotochemotherapyPhotosensitizing AgentsProstatic NeoplasmsReactive Oxygen SpeciesCell Line, TumorCell SurvivalHumansMaleMembrane Potential, MitochondrialNitric OxideIndocyanine GreenNitric OxidePhotosensitizing AgentsReactive Oxygen SpeciesIndocyanine greenNitric oxidePhotobiomodulationPhotodynamic therapyProstate cancerReactive oxygen species

Identifiers

PMID39560842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.